LIVE UPDATES: Fed Chair Jerome Powell to deliver major speech at Jackson Hole
Cathie Wood’s ARK ETFs have once again adjusted their portfolios, as revealed in the daily trade report for Thursday, March 27th, 2025. In a notable move, the ETFs sold a significant amount of Illumina Inc (NASDAQ:ILMN) and completely exited their position in Repare Therapeutics Inc (NASDAQ:RPTX).
The largest trade of the day involved Repare Therapeutics, with ARK’s ARKG ETF selling all 112,880 shares, equating to a total dollar value of $114,008. This sale marks a continuation of ARK’s recent trend of reducing exposure to the biotechnology company, which has been observed over the past week.
In addition to the Repare Therapeutics sale, ARK ETFs sold a combined total of 14,400 shares of Illumina Inc, with 11,823 shares sold through the ARKK ETF and 2,577 shares through the ARKG ETF. The move is part of a broader pattern of ARK reducing its stake in the genomic sequencing company, as similar sell-offs were recorded in the previous trading sessions.
Investors following ARK’s trading behavior might recall the consistent accumulation of Pacific Biosciences of California Inc (NASDAQ:PACB) shares in recent days. However, today’s report did not indicate further purchases, suggesting a pause in the buying spree for the genetic analysis company.
While today’s report focused on sell-offs, it’s important for investors to monitor ARK’s trading activity across all holdings to understand the investment firm’s broader strategy. The daily trade reports provide a snapshot of ARK’s dynamic approach to managing their ETFs, as they navigate the ever-changing landscape of innovative and disruptive companies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.